Global Antiandrogen Market Research Report 2024, Forecast to 2032
Report Overview
An antiandrogen is a drug that blocks the effects of androgens, such as testosterone and dihydrotestosterone (DHT). Androgens are male sex hormones that play a role in many bodily functions, including sexual development, muscle growth, and bone density.
The global Antiandrogen market size was estimated at USD 6650 million in 2023 and is projected to reach USD 10859.18 million by 2032, exhibiting a CAGR of 5.60% during the forecast period.
North America Antiandrogen market size was estimated at USD 1903.14 million in 2023, at a CAGR of 4.80% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Antiandrogen market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiandrogen Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiandrogen market in any manner.
Global Antiandrogen Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Orion Corporation
Hengrui
Bayer
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Market Segmentation (by Type)
Steroidal Antiandrogen
Nonsteroidal Antiandrogen
Market Segmentation (by Application)
Prostate Cancer
Benign Prostatic Hyperplasia
Polycystic Ovary Syndrome (POCS)
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiandrogen Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiandrogen, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
An antiandrogen is a drug that blocks the effects of androgens, such as testosterone and dihydrotestosterone (DHT). Androgens are male sex hormones that play a role in many bodily functions, including sexual development, muscle growth, and bone density.
The global Antiandrogen market size was estimated at USD 6650 million in 2023 and is projected to reach USD 10859.18 million by 2032, exhibiting a CAGR of 5.60% during the forecast period.
North America Antiandrogen market size was estimated at USD 1903.14 million in 2023, at a CAGR of 4.80% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Antiandrogen market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiandrogen Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiandrogen market in any manner.
Global Antiandrogen Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Orion Corporation
Hengrui
Bayer
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Market Segmentation (by Type)
Steroidal Antiandrogen
Nonsteroidal Antiandrogen
Market Segmentation (by Application)
Prostate Cancer
Benign Prostatic Hyperplasia
Polycystic Ovary Syndrome (POCS)
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Antiandrogen Market
- Overview of the regional outlook of the Antiandrogen Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiandrogen Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiandrogen, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antiandrogen
1.2 Key Market Segments
1.2.1 Antiandrogen Segment by Type
1.2.2 Antiandrogen Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIANDROGEN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiandrogen Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Antiandrogen Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIANDROGEN MARKET COMPETITIVE LANDSCAPE
3.1 Global Antiandrogen Sales by Manufacturers (2019-2024)
3.2 Global Antiandrogen Revenue Market Share by Manufacturers (2019-2024)
3.3 Antiandrogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antiandrogen Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antiandrogen Sales Sites, Area Served, Product Type
3.6 Antiandrogen Market Competitive Situation and Trends
3.6.1 Antiandrogen Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antiandrogen Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTIANDROGEN INDUSTRY CHAIN ANALYSIS
4.1 Antiandrogen Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIANDROGEN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTIANDROGEN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiandrogen Sales Market Share by Type (2019-2024)
6.3 Global Antiandrogen Market Size Market Share by Type (2019-2024)
6.4 Global Antiandrogen Price by Type (2019-2024)
7 ANTIANDROGEN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiandrogen Market Sales by Application (2019-2024)
7.3 Global Antiandrogen Market Size (M USD) by Application (2019-2024)
7.4 Global Antiandrogen Sales Growth Rate by Application (2019-2024)
8 ANTIANDROGEN MARKET CONSUMPTION BY REGION
8.1 Global Antiandrogen Sales by Region
8.1.1 Global Antiandrogen Sales by Region
8.1.2 Global Antiandrogen Sales Market Share by Region
8.2 North America
8.2.1 North America Antiandrogen Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antiandrogen Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antiandrogen Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antiandrogen Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antiandrogen Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTIANDROGEN MARKET PRODUCTION BY REGION
9.1 Global Production of Antiandrogen by Region (2019-2024)
9.2 Global Antiandrogen Revenue Market Share by Region (2019-2024)
9.3 Global Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Antiandrogen Production
9.4.1 North America Antiandrogen Production Growth Rate (2019-2024)
9.4.2 North America Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Antiandrogen Production
9.5.1 Europe Antiandrogen Production Growth Rate (2019-2024)
9.5.2 Europe Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Antiandrogen Production (2019-2024)
9.6.1 Japan Antiandrogen Production Growth Rate (2019-2024)
9.6.2 Japan Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Antiandrogen Production (2019-2024)
9.7.1 China Antiandrogen Production Growth Rate (2019-2024)
9.7.2 China Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Antiandrogen Basic Information
10.1.2 Pfizer Antiandrogen Product Overview
10.1.3 Pfizer Antiandrogen Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Antiandrogen SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Antiandrogen Basic Information
10.2.2 Johnson and Johnson Antiandrogen Product Overview
10.2.3 Johnson and Johnson Antiandrogen Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson Antiandrogen SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Antiandrogen Basic Information
10.3.2 AstraZeneca Antiandrogen Product Overview
10.3.3 AstraZeneca Antiandrogen Product Market Performance
10.3.4 AstraZeneca Antiandrogen SWOT Analysis
10.3.5 AstraZeneca Business Overview
10.3.6 AstraZeneca Recent Developments
10.4 Astellas
10.4.1 Astellas Antiandrogen Basic Information
10.4.2 Astellas Antiandrogen Product Overview
10.4.3 Astellas Antiandrogen Product Market Performance
10.4.4 Astellas Business Overview
10.4.5 Astellas Recent Developments
10.5 Merck
10.5.1 Merck Antiandrogen Basic Information
10.5.2 Merck Antiandrogen Product Overview
10.5.3 Merck Antiandrogen Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 Sanofi
10.6.1 Sanofi Antiandrogen Basic Information
10.6.2 Sanofi Antiandrogen Product Overview
10.6.3 Sanofi Antiandrogen Product Market Performance
10.6.4 Sanofi Business Overview
10.6.5 Sanofi Recent Developments
10.7 Orion Corporation
10.7.1 Orion Corporation Antiandrogen Basic Information
10.7.2 Orion Corporation Antiandrogen Product Overview
10.7.3 Orion Corporation Antiandrogen Product Market Performance
10.7.4 Orion Corporation Business Overview
10.7.5 Orion Corporation Recent Developments
10.8 Hengrui
10.8.1 Hengrui Antiandrogen Basic Information
10.8.2 Hengrui Antiandrogen Product Overview
10.8.3 Hengrui Antiandrogen Product Market Performance
10.8.4 Hengrui Business Overview
10.8.5 Hengrui Recent Developments
10.9 Bayer
10.9.1 Bayer Antiandrogen Basic Information
10.9.2 Bayer Antiandrogen Product Overview
10.9.3 Bayer Antiandrogen Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Schering-Plough
10.10.1 Schering-Plough Antiandrogen Basic Information
10.10.2 Schering-Plough Antiandrogen Product Overview
10.10.3 Schering-Plough Antiandrogen Product Market Performance
10.10.4 Schering-Plough Business Overview
10.10.5 Schering-Plough Recent Developments
10.11 Hinova Pharma
10.11.1 Hinova Pharma Antiandrogen Basic Information
10.11.2 Hinova Pharma Antiandrogen Product Overview
10.11.3 Hinova Pharma Antiandrogen Product Market Performance
10.11.4 Hinova Pharma Business Overview
10.11.5 Hinova Pharma Recent Developments
10.12 Jiangsu Hengrui Pharmaceuticals
10.12.1 Jiangsu Hengrui Pharmaceuticals Antiandrogen Basic Information
10.12.2 Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Overview
10.12.3 Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Market Performance
10.12.4 Jiangsu Hengrui Pharmaceuticals Business Overview
10.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
11 ANTIANDROGEN MARKET FORECAST BY REGION
11.1 Global Antiandrogen Market Size Forecast
11.2 Global Antiandrogen Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antiandrogen Market Size Forecast by Country
11.2.3 Asia Pacific Antiandrogen Market Size Forecast by Region
11.2.4 South America Antiandrogen Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Antiandrogen by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Antiandrogen Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Antiandrogen by Type (2025-2032)
12.1.2 Global Antiandrogen Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Antiandrogen by Type (2025-2032)
12.2 Global Antiandrogen Market Forecast by Application (2025-2032)
12.2.1 Global Antiandrogen Sales (K Units) Forecast by Application
12.2.2 Global Antiandrogen Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antiandrogen
1.2 Key Market Segments
1.2.1 Antiandrogen Segment by Type
1.2.2 Antiandrogen Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIANDROGEN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiandrogen Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Antiandrogen Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIANDROGEN MARKET COMPETITIVE LANDSCAPE
3.1 Global Antiandrogen Sales by Manufacturers (2019-2024)
3.2 Global Antiandrogen Revenue Market Share by Manufacturers (2019-2024)
3.3 Antiandrogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antiandrogen Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antiandrogen Sales Sites, Area Served, Product Type
3.6 Antiandrogen Market Competitive Situation and Trends
3.6.1 Antiandrogen Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antiandrogen Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTIANDROGEN INDUSTRY CHAIN ANALYSIS
4.1 Antiandrogen Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIANDROGEN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTIANDROGEN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiandrogen Sales Market Share by Type (2019-2024)
6.3 Global Antiandrogen Market Size Market Share by Type (2019-2024)
6.4 Global Antiandrogen Price by Type (2019-2024)
7 ANTIANDROGEN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiandrogen Market Sales by Application (2019-2024)
7.3 Global Antiandrogen Market Size (M USD) by Application (2019-2024)
7.4 Global Antiandrogen Sales Growth Rate by Application (2019-2024)
8 ANTIANDROGEN MARKET CONSUMPTION BY REGION
8.1 Global Antiandrogen Sales by Region
8.1.1 Global Antiandrogen Sales by Region
8.1.2 Global Antiandrogen Sales Market Share by Region
8.2 North America
8.2.1 North America Antiandrogen Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antiandrogen Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antiandrogen Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antiandrogen Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antiandrogen Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTIANDROGEN MARKET PRODUCTION BY REGION
9.1 Global Production of Antiandrogen by Region (2019-2024)
9.2 Global Antiandrogen Revenue Market Share by Region (2019-2024)
9.3 Global Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Antiandrogen Production
9.4.1 North America Antiandrogen Production Growth Rate (2019-2024)
9.4.2 North America Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Antiandrogen Production
9.5.1 Europe Antiandrogen Production Growth Rate (2019-2024)
9.5.2 Europe Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Antiandrogen Production (2019-2024)
9.6.1 Japan Antiandrogen Production Growth Rate (2019-2024)
9.6.2 Japan Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Antiandrogen Production (2019-2024)
9.7.1 China Antiandrogen Production Growth Rate (2019-2024)
9.7.2 China Antiandrogen Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Antiandrogen Basic Information
10.1.2 Pfizer Antiandrogen Product Overview
10.1.3 Pfizer Antiandrogen Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Antiandrogen SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Antiandrogen Basic Information
10.2.2 Johnson and Johnson Antiandrogen Product Overview
10.2.3 Johnson and Johnson Antiandrogen Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson Antiandrogen SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Antiandrogen Basic Information
10.3.2 AstraZeneca Antiandrogen Product Overview
10.3.3 AstraZeneca Antiandrogen Product Market Performance
10.3.4 AstraZeneca Antiandrogen SWOT Analysis
10.3.5 AstraZeneca Business Overview
10.3.6 AstraZeneca Recent Developments
10.4 Astellas
10.4.1 Astellas Antiandrogen Basic Information
10.4.2 Astellas Antiandrogen Product Overview
10.4.3 Astellas Antiandrogen Product Market Performance
10.4.4 Astellas Business Overview
10.4.5 Astellas Recent Developments
10.5 Merck
10.5.1 Merck Antiandrogen Basic Information
10.5.2 Merck Antiandrogen Product Overview
10.5.3 Merck Antiandrogen Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 Sanofi
10.6.1 Sanofi Antiandrogen Basic Information
10.6.2 Sanofi Antiandrogen Product Overview
10.6.3 Sanofi Antiandrogen Product Market Performance
10.6.4 Sanofi Business Overview
10.6.5 Sanofi Recent Developments
10.7 Orion Corporation
10.7.1 Orion Corporation Antiandrogen Basic Information
10.7.2 Orion Corporation Antiandrogen Product Overview
10.7.3 Orion Corporation Antiandrogen Product Market Performance
10.7.4 Orion Corporation Business Overview
10.7.5 Orion Corporation Recent Developments
10.8 Hengrui
10.8.1 Hengrui Antiandrogen Basic Information
10.8.2 Hengrui Antiandrogen Product Overview
10.8.3 Hengrui Antiandrogen Product Market Performance
10.8.4 Hengrui Business Overview
10.8.5 Hengrui Recent Developments
10.9 Bayer
10.9.1 Bayer Antiandrogen Basic Information
10.9.2 Bayer Antiandrogen Product Overview
10.9.3 Bayer Antiandrogen Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Schering-Plough
10.10.1 Schering-Plough Antiandrogen Basic Information
10.10.2 Schering-Plough Antiandrogen Product Overview
10.10.3 Schering-Plough Antiandrogen Product Market Performance
10.10.4 Schering-Plough Business Overview
10.10.5 Schering-Plough Recent Developments
10.11 Hinova Pharma
10.11.1 Hinova Pharma Antiandrogen Basic Information
10.11.2 Hinova Pharma Antiandrogen Product Overview
10.11.3 Hinova Pharma Antiandrogen Product Market Performance
10.11.4 Hinova Pharma Business Overview
10.11.5 Hinova Pharma Recent Developments
10.12 Jiangsu Hengrui Pharmaceuticals
10.12.1 Jiangsu Hengrui Pharmaceuticals Antiandrogen Basic Information
10.12.2 Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Overview
10.12.3 Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Market Performance
10.12.4 Jiangsu Hengrui Pharmaceuticals Business Overview
10.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
11 ANTIANDROGEN MARKET FORECAST BY REGION
11.1 Global Antiandrogen Market Size Forecast
11.2 Global Antiandrogen Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antiandrogen Market Size Forecast by Country
11.2.3 Asia Pacific Antiandrogen Market Size Forecast by Region
11.2.4 South America Antiandrogen Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Antiandrogen by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Antiandrogen Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Antiandrogen by Type (2025-2032)
12.1.2 Global Antiandrogen Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Antiandrogen by Type (2025-2032)
12.2 Global Antiandrogen Market Forecast by Application (2025-2032)
12.2.1 Global Antiandrogen Sales (K Units) Forecast by Application
12.2.2 Global Antiandrogen Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antiandrogen Market Size Comparison by Region (M USD)
Table 5. Global Antiandrogen Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Antiandrogen Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antiandrogen Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antiandrogen Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiandrogen as of 2022)
Table 10. Global Market Antiandrogen Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antiandrogen Sales Sites and Area Served
Table 12. Manufacturers Antiandrogen Product Type
Table 13. Global Antiandrogen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antiandrogen
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiandrogen Market Challenges
Table 22. Global Antiandrogen Sales by Type (K Units)
Table 23. Global Antiandrogen Market Size by Type (M USD)
Table 24. Global Antiandrogen Sales (K Units) by Type (2019-2024)
Table 25. Global Antiandrogen Sales Market Share by Type (2019-2024)
Table 26. Global Antiandrogen Market Size (M USD) by Type (2019-2024)
Table 27. Global Antiandrogen Market Size Share by Type (2019-2024)
Table 28. Global Antiandrogen Price (USD/Unit) by Type (2019-2024)
Table 29. Global Antiandrogen Sales (K Units) by Application
Table 30. Global Antiandrogen Market Size by Application
Table 31. Global Antiandrogen Sales by Application (2019-2024) & (K Units)
Table 32. Global Antiandrogen Sales Market Share by Application (2019-2024)
Table 33. Global Antiandrogen Sales by Application (2019-2024) & (M USD)
Table 34. Global Antiandrogen Market Share by Application (2019-2024)
Table 35. Global Antiandrogen Sales Growth Rate by Application (2019-2024)
Table 36. Global Antiandrogen Sales by Region (2019-2024) & (K Units)
Table 37. Global Antiandrogen Sales Market Share by Region (2019-2024)
Table 38. North America Antiandrogen Sales by Country (2019-2024) & (K Units)
Table 39. Europe Antiandrogen Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Antiandrogen Sales by Region (2019-2024) & (K Units)
Table 41. South America Antiandrogen Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Antiandrogen Sales by Region (2019-2024) & (K Units)
Table 43. Global Antiandrogen Production (K Units) by Region (2019-2024)
Table 44. Global Antiandrogen Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Antiandrogen Revenue Market Share by Region (2019-2024)
Table 46. Global Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Pfizer Antiandrogen Basic Information
Table 52. Pfizer Antiandrogen Product Overview
Table 53. Pfizer Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Antiandrogen SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Johnson and Johnson Antiandrogen Basic Information
Table 58. Johnson and Johnson Antiandrogen Product Overview
Table 59. Johnson and Johnson Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Johnson and Johnson Business Overview
Table 61. Johnson and Johnson Antiandrogen SWOT Analysis
Table 62. Johnson and Johnson Recent Developments
Table 63. AstraZeneca Antiandrogen Basic Information
Table 64. AstraZeneca Antiandrogen Product Overview
Table 65. AstraZeneca Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. AstraZeneca Antiandrogen SWOT Analysis
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Recent Developments
Table 69. Astellas Antiandrogen Basic Information
Table 70. Astellas Antiandrogen Product Overview
Table 71. Astellas Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Astellas Business Overview
Table 73. Astellas Recent Developments
Table 74. Merck Antiandrogen Basic Information
Table 75. Merck Antiandrogen Product Overview
Table 76. Merck Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Merck Business Overview
Table 78. Merck Recent Developments
Table 79. Sanofi Antiandrogen Basic Information
Table 80. Sanofi Antiandrogen Product Overview
Table 81. Sanofi Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Sanofi Business Overview
Table 83. Sanofi Recent Developments
Table 84. Orion Corporation Antiandrogen Basic Information
Table 85. Orion Corporation Antiandrogen Product Overview
Table 86. Orion Corporation Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Orion Corporation Business Overview
Table 88. Orion Corporation Recent Developments
Table 89. Hengrui Antiandrogen Basic Information
Table 90. Hengrui Antiandrogen Product Overview
Table 91. Hengrui Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Hengrui Business Overview
Table 93. Hengrui Recent Developments
Table 94. Bayer Antiandrogen Basic Information
Table 95. Bayer Antiandrogen Product Overview
Table 96. Bayer Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Bayer Business Overview
Table 98. Bayer Recent Developments
Table 99. Schering-Plough Antiandrogen Basic Information
Table 100. Schering-Plough Antiandrogen Product Overview
Table 101. Schering-Plough Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Schering-Plough Business Overview
Table 103. Schering-Plough Recent Developments
Table 104. Hinova Pharma Antiandrogen Basic Information
Table 105. Hinova Pharma Antiandrogen Product Overview
Table 106. Hinova Pharma Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Hinova Pharma Business Overview
Table 108. Hinova Pharma Recent Developments
Table 109. Jiangsu Hengrui Pharmaceuticals Antiandrogen Basic Information
Table 110. Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Overview
Table 111. Jiangsu Hengrui Pharmaceuticals Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 113. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 114. Global Antiandrogen Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Antiandrogen Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Antiandrogen Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Antiandrogen Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Antiandrogen Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Antiandrogen Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Antiandrogen Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Antiandrogen Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Antiandrogen Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Antiandrogen Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Antiandrogen Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Antiandrogen Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Antiandrogen Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antiandrogen Market Size Comparison by Region (M USD)
Table 5. Global Antiandrogen Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Antiandrogen Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antiandrogen Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antiandrogen Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiandrogen as of 2022)
Table 10. Global Market Antiandrogen Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antiandrogen Sales Sites and Area Served
Table 12. Manufacturers Antiandrogen Product Type
Table 13. Global Antiandrogen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antiandrogen
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiandrogen Market Challenges
Table 22. Global Antiandrogen Sales by Type (K Units)
Table 23. Global Antiandrogen Market Size by Type (M USD)
Table 24. Global Antiandrogen Sales (K Units) by Type (2019-2024)
Table 25. Global Antiandrogen Sales Market Share by Type (2019-2024)
Table 26. Global Antiandrogen Market Size (M USD) by Type (2019-2024)
Table 27. Global Antiandrogen Market Size Share by Type (2019-2024)
Table 28. Global Antiandrogen Price (USD/Unit) by Type (2019-2024)
Table 29. Global Antiandrogen Sales (K Units) by Application
Table 30. Global Antiandrogen Market Size by Application
Table 31. Global Antiandrogen Sales by Application (2019-2024) & (K Units)
Table 32. Global Antiandrogen Sales Market Share by Application (2019-2024)
Table 33. Global Antiandrogen Sales by Application (2019-2024) & (M USD)
Table 34. Global Antiandrogen Market Share by Application (2019-2024)
Table 35. Global Antiandrogen Sales Growth Rate by Application (2019-2024)
Table 36. Global Antiandrogen Sales by Region (2019-2024) & (K Units)
Table 37. Global Antiandrogen Sales Market Share by Region (2019-2024)
Table 38. North America Antiandrogen Sales by Country (2019-2024) & (K Units)
Table 39. Europe Antiandrogen Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Antiandrogen Sales by Region (2019-2024) & (K Units)
Table 41. South America Antiandrogen Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Antiandrogen Sales by Region (2019-2024) & (K Units)
Table 43. Global Antiandrogen Production (K Units) by Region (2019-2024)
Table 44. Global Antiandrogen Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Antiandrogen Revenue Market Share by Region (2019-2024)
Table 46. Global Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Antiandrogen Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Pfizer Antiandrogen Basic Information
Table 52. Pfizer Antiandrogen Product Overview
Table 53. Pfizer Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Antiandrogen SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Johnson and Johnson Antiandrogen Basic Information
Table 58. Johnson and Johnson Antiandrogen Product Overview
Table 59. Johnson and Johnson Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Johnson and Johnson Business Overview
Table 61. Johnson and Johnson Antiandrogen SWOT Analysis
Table 62. Johnson and Johnson Recent Developments
Table 63. AstraZeneca Antiandrogen Basic Information
Table 64. AstraZeneca Antiandrogen Product Overview
Table 65. AstraZeneca Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. AstraZeneca Antiandrogen SWOT Analysis
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Recent Developments
Table 69. Astellas Antiandrogen Basic Information
Table 70. Astellas Antiandrogen Product Overview
Table 71. Astellas Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Astellas Business Overview
Table 73. Astellas Recent Developments
Table 74. Merck Antiandrogen Basic Information
Table 75. Merck Antiandrogen Product Overview
Table 76. Merck Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Merck Business Overview
Table 78. Merck Recent Developments
Table 79. Sanofi Antiandrogen Basic Information
Table 80. Sanofi Antiandrogen Product Overview
Table 81. Sanofi Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Sanofi Business Overview
Table 83. Sanofi Recent Developments
Table 84. Orion Corporation Antiandrogen Basic Information
Table 85. Orion Corporation Antiandrogen Product Overview
Table 86. Orion Corporation Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Orion Corporation Business Overview
Table 88. Orion Corporation Recent Developments
Table 89. Hengrui Antiandrogen Basic Information
Table 90. Hengrui Antiandrogen Product Overview
Table 91. Hengrui Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Hengrui Business Overview
Table 93. Hengrui Recent Developments
Table 94. Bayer Antiandrogen Basic Information
Table 95. Bayer Antiandrogen Product Overview
Table 96. Bayer Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Bayer Business Overview
Table 98. Bayer Recent Developments
Table 99. Schering-Plough Antiandrogen Basic Information
Table 100. Schering-Plough Antiandrogen Product Overview
Table 101. Schering-Plough Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Schering-Plough Business Overview
Table 103. Schering-Plough Recent Developments
Table 104. Hinova Pharma Antiandrogen Basic Information
Table 105. Hinova Pharma Antiandrogen Product Overview
Table 106. Hinova Pharma Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Hinova Pharma Business Overview
Table 108. Hinova Pharma Recent Developments
Table 109. Jiangsu Hengrui Pharmaceuticals Antiandrogen Basic Information
Table 110. Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Overview
Table 111. Jiangsu Hengrui Pharmaceuticals Antiandrogen Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 113. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 114. Global Antiandrogen Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Antiandrogen Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Antiandrogen Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Antiandrogen Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Antiandrogen Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Antiandrogen Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Antiandrogen Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Antiandrogen Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Antiandrogen Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Antiandrogen Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Antiandrogen Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Antiandrogen Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Antiandrogen Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Antiandrogen Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antiandrogen
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiandrogen Market Size (M USD), 2019-2032
Figure 5. Global Antiandrogen Market Size (M USD) (2019-2032)
Figure 6. Global Antiandrogen Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiandrogen Market Size by Country (M USD)
Figure 11. Antiandrogen Sales Share by Manufacturers in 2023
Figure 12. Global Antiandrogen Revenue Share by Manufacturers in 2023
Figure 13. Antiandrogen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antiandrogen Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antiandrogen Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antiandrogen Market Share by Type
Figure 18. Sales Market Share of Antiandrogen by Type (2019-2024)
Figure 19. Sales Market Share of Antiandrogen by Type in 2023
Figure 20. Market Size Share of Antiandrogen by Type (2019-2024)
Figure 21. Market Size Market Share of Antiandrogen by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antiandrogen Market Share by Application
Figure 24. Global Antiandrogen Sales Market Share by Application (2019-2024)
Figure 25. Global Antiandrogen Sales Market Share by Application in 2023
Figure 26. Global Antiandrogen Market Share by Application (2019-2024)
Figure 27. Global Antiandrogen Market Share by Application in 2023
Figure 28. Global Antiandrogen Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antiandrogen Sales Market Share by Region (2019-2024)
Figure 30. North America Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Antiandrogen Sales Market Share by Country in 2023
Figure 32. U.S. Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Antiandrogen Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Antiandrogen Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Antiandrogen Sales Market Share by Country in 2023
Figure 37. Germany Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Antiandrogen Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Antiandrogen Sales Market Share by Region in 2023
Figure 44. China Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Antiandrogen Sales and Growth Rate (K Units)
Figure 50. South America Antiandrogen Sales Market Share by Country in 2023
Figure 51. Brazil Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Antiandrogen Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Antiandrogen Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Antiandrogen Production Market Share by Region (2019-2024)
Figure 62. North America Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 65. China Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Antiandrogen Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Antiandrogen Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Antiandrogen Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Antiandrogen Market Share Forecast by Type (2025-2032)
Figure 70. Global Antiandrogen Sales Forecast by Application (2025-2032)
Figure 71. Global Antiandrogen Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Antiandrogen
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiandrogen Market Size (M USD), 2019-2032
Figure 5. Global Antiandrogen Market Size (M USD) (2019-2032)
Figure 6. Global Antiandrogen Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiandrogen Market Size by Country (M USD)
Figure 11. Antiandrogen Sales Share by Manufacturers in 2023
Figure 12. Global Antiandrogen Revenue Share by Manufacturers in 2023
Figure 13. Antiandrogen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antiandrogen Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antiandrogen Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antiandrogen Market Share by Type
Figure 18. Sales Market Share of Antiandrogen by Type (2019-2024)
Figure 19. Sales Market Share of Antiandrogen by Type in 2023
Figure 20. Market Size Share of Antiandrogen by Type (2019-2024)
Figure 21. Market Size Market Share of Antiandrogen by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antiandrogen Market Share by Application
Figure 24. Global Antiandrogen Sales Market Share by Application (2019-2024)
Figure 25. Global Antiandrogen Sales Market Share by Application in 2023
Figure 26. Global Antiandrogen Market Share by Application (2019-2024)
Figure 27. Global Antiandrogen Market Share by Application in 2023
Figure 28. Global Antiandrogen Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antiandrogen Sales Market Share by Region (2019-2024)
Figure 30. North America Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Antiandrogen Sales Market Share by Country in 2023
Figure 32. U.S. Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Antiandrogen Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Antiandrogen Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Antiandrogen Sales Market Share by Country in 2023
Figure 37. Germany Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Antiandrogen Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Antiandrogen Sales Market Share by Region in 2023
Figure 44. China Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Antiandrogen Sales and Growth Rate (K Units)
Figure 50. South America Antiandrogen Sales Market Share by Country in 2023
Figure 51. Brazil Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Antiandrogen Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Antiandrogen Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Antiandrogen Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Antiandrogen Production Market Share by Region (2019-2024)
Figure 62. North America Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 65. China Antiandrogen Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Antiandrogen Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Antiandrogen Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Antiandrogen Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Antiandrogen Market Share Forecast by Type (2025-2032)
Figure 70. Global Antiandrogen Sales Forecast by Application (2025-2032)
Figure 71. Global Antiandrogen Market Share Forecast by Application (2025-2032)
